Raia Drogasil S.A.
Raia Drogasil S.A. (RADLY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
radly · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Pharmaceuticals · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Raia Drogasil S.A.You RADLY | $6.2B | 22.75x | -15.3% | $0.78 |
 Clicks Group Limited CLCGY | $3.3B | 28.13x | +4.7% | $26.57 |
 ConvaTec Group Plc CNVVF | $4.7B | 33.16x | +23.4% | $0.09 |
 ConvaTec Group Plc CNVVY | $5.2B | 37.72x | +40.4% | $0.35 |
 COSMOS Pharmaceutical Corporation CSMYF | $3.3B | 16.92x | -37.0% | $390.86 |
 DiaSorin S.p.A. DSRLF | $4.5B | 24.15x | -10.1% | $2.68 |
 Fielmann AG FLMNF | $4.4B | 21.13x | -21.4% | $2.43 |
Industry Average 6 peers with valid PE | — | 26.87x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Raia Drogasil S.A. (RADLY) measures how much investors pay for each dollar of the company's trailing earnings. RADLY's current PE ratio of 22.75x is calculated by dividing its stock price of $3.52 by its TTM earnings per share of $0.78.
Frequently asked questions
RADLY pe ratio · 6 questionsRADLY's current PE ratio is 22.75x as of 2026-06-09, based on a stock price of $3.52 and TTM EPS of $0.78. Data sourced from Financial Modeling Prep via RADLY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Raia Drogasil S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09